Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors
Fig 5
Hematoxylin-eosin and RANKL stains on GCTB.
(5a) Tumor stromal cells and osteoclast-like giant cells were observed. (5b) RANKL-positive stromal cells surrounding osteoclast-like giant cells were detected.